Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

Clinical trial NCT05831631 · RECRUITING

Trial details

NCT number: NCT05831631
Sponsor: Pietro Mortini, MD, Prof.
Status: RECRUITING
Study type: OBSERVATIONAL

Brain Tumor, Primary Brain Tumor - Metastatic

Start date: 2022-08-01
Primary completion: 2028-07-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.